Bangalore Institute of Oncology Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT01766323
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Bangalore Institute of Oncology

Active Ingredients

Drugs in Phase 3 Trials (3)

modafinil (provigil) (1 trial)

Pegfilgrastim (1 trial)

sargramostim (leukine) (1 trial)

Drugs in Other Trials (1)

fluorocholine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neutropenia (Phase 3)

Sleepiness (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4